Firm Advises Elucidata on $16 Million Series A
- Client Highlights
- Life Sciences
On September 27, 2022, TechBio company Elucidata announced that it has raised $16 million in a Series A fundraising, which was led by Eight Roads Ventures. F-Prime Capital, IvyCap Ventures, and Hyperplane Venture Capital also participated. Wilson Sonsini Goodrich & Rosati advised Elucidata on the transaction.
Elucidata focuses on life sciences research and development through its data-centric Machine Learning Operations platform Polly, which enables pharmaceutical and diagnostic companies to adopt a data-centric approach for artificial intelligence and machine learning. Polly has been used on over 2.5 million biomolecular datasets. The company was founded in 2015 by University of Chicago and MIT graduate Dr. Abhishek Jha and IIT Delhi alumnus Swetabh Pathak.
For more information, please see Elucidata’s press release.